Stephanie V. Blank
Mount Sinai Hospital(US)Icahn School of Medicine at Mount Sinai(US)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, BRCA gene mutations in cancer, Endometrial and Cervical Cancer Treatments, Cancer Genomics and Diagnostics, COVID-19 and healthcare impacts
Most-Cited Works
- → OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer(2012)1,368 cited
- → A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population(2010)341 cited
- → Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer(2015)310 cited
- → Uterine carcinosarcoma: A review of the literature(2015)219 cited
- → Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors(2020)202 cited
- → The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer(2005)174 cited